Loading clinical trials...
Loading clinical trials...
HEPMET-1: Evaluate the Feasibility, Mental Sideeffects and the Efficacy of Hepatitis C Treatment in a Methadone Maintenance Treated (MMT) Opioid Addicted Group.
Conditions
Interventions
Ribavirin
Pegylated Interferon
Locations
2
Norway
Soerlandet Hospital HF
Kristiansand, Vest-Agder, Norway
Addiction Unit, Sorlandet Hospital
Kristiansand, Vest-Agder, Norway
Start Date
March 1, 2006
Primary Completion Date
June 1, 2007
Completion Date
January 1, 2008
Last Updated
March 28, 2008
NCT06632444
NCT02815891
NCT07024641
NCT07442760
NCT06953479
NCT06819917
Lead Sponsor
Sorlandet Hospital HF
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions